We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Lamictal TM, Haloperidol Decanoate in Schizophrenia (CMCOBaku)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00947375
Recruitment Status : Terminated (All of the mentioned aim and objectives were achieved before the February 2007)
First Posted : July 28, 2009
Last Update Posted : July 28, 2009
Information provided by:
Central Mental Clinic for Outpatients of Baku City

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Primary Completion Date : January 2006
  Study Completion Date : January 2007

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 August 10, 2009 September 4, 2009
2 June 7, 2010 July 7, 2010